Dozens of machine learning algorithms require computing the inverse of a matrix. Computing a matrix inverse is conceptually easy, but implementation is one of the most challenging tasks in numerical ...

Is Poke an OpenClaw for the rest of us? That’s the idea coming from a new startup offering an AI agent that you can access via iMessage, SMS, Telegram, and, in some markets, WhatsApp. The AI agent ...

The Close Scrutiny ARC Operation spawns Vaporizer enemies and Assessors unique to this map condition. However, loot value is low under this condition, and the main source of loot is Assessors. Close ...

Companies partnering to drive solid-state transformer technology for AI data centres and industrial power applications Infineon and DG Matrix, a developer of Solid-State Transformer (SST) solutions, ...

RICHMOND, Va. — A new mixed-use development project is in the works on West Moore Street in Scott's Addition. City officials and developers with Hoffman & Associates and DeBartolo Development broke ...

Amid a flurry of moves during NFL free agency’s legal tampering period, it looks as if the Las Vegas Raiders have made a few smart additions. New head coach Klint Kubiak and second-year general ...

Suffering from hair envy? You can now use the same hair products that Manon, Yoonchae, Sophia, Megan, Lara, and Daniela use to get their glossy locks. Manon's go-to products from Matrix are a ...

Denmark’s defense minister said Greenland did not need health care assistance, a day after President Trump said he planned to send a “great hospital boat” to the island. By Ali Watkins and Amelia ...

Per the terms of the agreement, Novavax will receive an upfront payment of $30 million from Pfizer and is eligible to earn up to $500 million in potential development and commercial milestone payments ...

Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine programs. The tech, called Matrix-M, is designed to trigger an immune ...

Novavax has agreed to a deal to let Pfizer use Matrix-M adjuvant in its products for an upfront payment of $30 million and up to another $500 million in milestone payments. The biotech company said ...